1995
DOI: 10.1210/jcem.80.2.7852535
|View full text |Cite
|
Sign up to set email alerts
|

The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.

Abstract: Hexarelin (Hex) is a new synthetic hexapeptide with potent growth hormone (GH)-releasing activity in both animals and men. We evaluated the GH response to a maximal dose of Hex (2 micrograms/kg iv) and GH-releasing hormone (GHRH) (1-29, 1 microgram/kg iv) in 45 short normal children (24 males and 21 females, age 5.9-14 yr, 24 prepubertal and 21 in Tanner stage 2 or 3 of pubertal maturation), in 10 prepubertal obese children (7 males and 3 females, age 7.5-12 yr), and in 5 subjects with organic hypopituitarism … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

1996
1996
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(5 citation statements)
references
References 25 publications
0
5
0
Order By: Relevance
“…However, Thomas et al (1997) have shown that GHRP-6 mediated the release of ACTH and cortisol in conscious rats. The mechanism by which ghrelin and synthetic GHSs stimulate the pituitary-adrenocortical axis is still unknown, but seems to be mediated via the hypothalamus as it is lost after cutting the pituitary stalk (Loche et al, 1995). They may interact with hypothalamic peptides (e.g., corticotrophin-releasing hormone, arginine vasopressin, and neuropeptide Y) controlling ACTH release (Broglio et al, 2003;Dickson and Luckman, 1997;Korbonits et al, 1999;Thomas et al, 1997), most probably primarily via arginine vasopressin (Korbonits et al, 1999).…”
Section: Ghrp-6mentioning
confidence: 99%
“…However, Thomas et al (1997) have shown that GHRP-6 mediated the release of ACTH and cortisol in conscious rats. The mechanism by which ghrelin and synthetic GHSs stimulate the pituitary-adrenocortical axis is still unknown, but seems to be mediated via the hypothalamus as it is lost after cutting the pituitary stalk (Loche et al, 1995). They may interact with hypothalamic peptides (e.g., corticotrophin-releasing hormone, arginine vasopressin, and neuropeptide Y) controlling ACTH release (Broglio et al, 2003;Dickson and Luckman, 1997;Korbonits et al, 1999;Thomas et al, 1997), most probably primarily via arginine vasopressin (Korbonits et al, 1999).…”
Section: Ghrp-6mentioning
confidence: 99%
“…Growth hormone (GH) secretion is suppressed in children with high BMI [39]. GH decreases in obese individuals, and peak GH levels are lower in obese children than in normal-weight children [40], also, GH in obese children with high BMI levels may result from decreased production and secretion of GH [41,42]. Research indicates that it is known that at any age, the average body height of girls is closer to the height they reach at adulthood than is the case for boys.…”
Section: Discussionmentioning
confidence: 99%
“…The GHRPs, namely GHRP-6 and HEX, have been found to have a strong stimulatory effect on GH secretion also in obesity (6)(7)(8)(9). Particularly in OB, the co-administration of GHRP-6 and GHRH allowed the existence of an unexpected pituitary GH pool to be demonstrated (6).…”
Section: Discussionmentioning
confidence: 99%
“…E Ghigo, Divisione di Endocrinologia, Ospedale Molinette, C.so A.M. Dogliotti 14,10126 Torino, Italy It is well known that GH secretion is reduced in obesity as a consequence of a reduction of secretory rate (1,2). Also the somatotrope responsiveness to all known GH secretagogues, including GHRH, has been shown to be reduced in obesity (1,(3)(4)(5)(6)(7)(8)(9). The pathogenesis of GH insufficiency in obesity is still unclear, although hypothalamic and/or metabolic alterations have been proposed as major causes (2)(3)(4)(10)(11)(12)(13)(14)(15)(16).…”
mentioning
confidence: 99%